Design and Characterization of Mucoadhesive Microspheres of Etodolac
Abstract
Mucoadhesive microspheres are drug delivery system intended for targeting a drug to particular region. Etodolac is a Non-steroidal anti-inflammatory drug. The objective of the present work was to develop sustain release of Etodolac loaded mucoadhesive microspheres due to relatively short residence time in the GIT tract before elimination. Mucoadhesive microspheres were prepared by non-aqueous solvent evaporation method using Carbopol 974P, HPMC K100M and HPMC K4M as the polymers. Central composite design was selected for the development of the formulation. Evaluation parameters like particle size, entrapment efficiency, shape and surface morphology, degree of swelling, drug content, in-vitro drug release study and in-vitro drug release study was done. Based on the results obtained from the preliminary formulations three optimized formulations were designed. The percentage mucoadhesion and swelling index of the optimized formulation was found in the range of 66-70 % and 82.50-83.84 % respectively. Optimized formulation releases 90.94% to 92.11% of drug at the end of 10 hours and follows zero order release kinetics.
Keywords:
Mucoadhesive microsphere, Etodolac, Optimization, MucoadhesionDOI
https://doi.org/10.25004/IJPSDR.2019.110302References
Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release. 1998; 51(2-3):115-122.
Vyas SP, Khar RK. Novel carrier system. In: Vyas SP, Ed (s). Targeted and controlled drug delivery: Novel carrier system. New Delhi: CBS Publishers and distributors, 2008, pp. 41-43.
Chowdary KPR, Rao YS. Design and in-vitro and in-vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: a technical note. AAPS PharmSciTech. 2009; 4:E39.
Chowdary KPR, Balatripura G. Design and in-vitro evaluation of mucoadhesive controlled release oral tablets of Glipizide. Ind J Pharm Sci. 2003; 65: 591-94.
Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003; 255:13-32.
Reddy DP, Swarnalatha D, Kishore HB, Dinakar A, Chaithanya V, Shivakumar K. Formulation and evaluation of extended release Etodolac, tablets. JITPS. 2010; 1(7): 294-7.
Strickmann DB, Balschke G. Isolation of an unknown metabolite of the non-steroidal anti-inflammatory drug Etodolac and its identification as 5-hydroxy Etodolac. J Pharm Biomed Analy. 2001; 25: 977-984.
Bhalani M, Subrahmanyam EVS, Shabaraya AR. New Analytical Methods and Their Validation for the Estimation of Etodolac in Bulk and Marketed Formulations. International Journal of Pharma Sciences and Research. 2015; 6:414-16.
Dutt KR, Yashoda P, Vasanthi R, Sundar PS, Raja MA, Rao KNV et al. Method Development And Validation Of Etodolac By Visible Spectroscopy. Indo American Journal of Pharmacy and International Peer Review Journal. 2017; 3(5): 245-53.
Acharya A, Kiran GBK, Ahmed MG, Paudel S. A novel approach to increase the bioavailability of candesartan cilexetil by proniosomal gel formulation: in-vitro and in-vivo evaluation. Int J Pharm Pharm Sci. 2016; 8(1): 241-46.
Garud N, Garud AL. Preparation and in-vitro evaluation of metformin microspheres using non-aqueous solvent evaporation technique. Trop J Pharm Res. 2012; 11(4): 577-83.
Acharya A, Ahmed MG, Rao BD, Vinay CH. Development and evaluation of ethosomal gel of lornoxicam for transdermal delivery: in-vitro and in-vivo evaluation. Manipal J Pharm Sci. 2016; 2(1): 13-20.
Acharya A, Acharya A, Paudel S. Comparative study on effect of natural and synthetic super disintegrants in the formulation of fast dissolving palatable tablets of an antiemetic drug. Am J Pharm Health Res. 2015; 3(6): 1-13.
Adhikari S, Kumar SK, Acharya A, Gulzar Ahmed MG, Aswini G, Sapkota A. An approach to enhance the solubility and bioavailability of poorly water soluble drug aceclofenac by self-emulsifying technique using natural oil. Am J PharmTech Res. 2016; 6(2): 229-41.
Published
Abstract Display: 495 
PDF Downloads: 813 
